Drugs.com - New Drug Approvals

Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59 at Increased Risk for RSV Disease

CAMBRIDGE, MA / ACCESS Newswire / June 12, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA (mRNA-1345), the Company's respiratory syncytial virus (RSV) vaccine, for the...

Jun 13, 2025 - 04:20
 0
Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59 at Increased Risk for RSV Disease
CAMBRIDGE, MA / ACCESS Newswire / June 12, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA (mRNA-1345), the Company's respiratory syncytial virus (RSV) vaccine, for the...
Read More

Tags:

Previous Article

2025 Ford F-150 Lobo Has Aggressive Looks And Lower Rear Suspension, But No Extr...

Next Article

FDA Approves Zusduri (mitomycin) for Recurrent Low-Grade Intermediate-Risk Non-M...

Related Posts

Uplizna (inebilizumab-cdon) is Now the First and Only F...

May 12, 2025  0

FDA Approves Ibtrozi (taletrectinib) for Advanced ROS1-Positive Non-Small Cell Lung Cancer

FDA Approves Ibtrozi (taletrectinib) for Advanced ROS1-...

Jun 12, 2025  0

FDA Approves mNEXSPIKE (COVID-19 Vaccine, mRNA) to Prevent COVID-19

FDA Approves mNEXSPIKE (COVID-19 Vaccine, mRNA) to Prev...

Jun 3, 2025  0